Nigeria Will Make Money From My HIV/AIDS Therapy Than Oil – Prof. Ezeibe

Professor Maduike Ezeibe of the Michael Okpara University of Agriculture, Umudike, Abia State, who is reported to discover a cure for the dreaded HIV/AIDS disease, has said his therapy could yield more revenue to Nigeria than crude oil.

The don, who made the claims at a press conference on the 48th Inaugural Lecture of the institution to be delivered by him on December 18, said the therapy could be a major source of endless revenue for Nigeria if the Federal Government partnered with him.

Professor Ezeibe said he had already acquired national patent right of the therapy and appealed to the Federal Government to assist him get international patent for the drug.

The Dean, School of Veterinary Medicine said the potency of the therapy had not been in doubt since 2013 when it was discovered after many decades of painstaking research works.

He disclosed that no fewer than two HIV/AIDS patients placed on the therapy tested negative of the pandemic every week since its debut.

The professor of Clinical Virology said that Nigeria stand to benefit immensely if “we commence commercial production” of the therapy which he currently gives to patients almost free of charge.
He further disclosed that the therapy known as Aluminum -magnesium silicate (MSAMS) had also proved to be efficacious in the treatment of prostrate and liver cancers.

Apart from treatment of viral diseases, the therapy according to him, can also be used in potentiating / stabilizing other drugs to enhance their efficacy.

Providing more insights on the efficacy of the therapy, Professor Ezeibe said the Nanoparticles in the drug enable it to reach the “HIV- reservoirs or sanctuary cells” inaccessible by medicines and mop up the virus hiding in such ‘sanctuaries’ and destroy them.

Prof. Ezeibe, who maintained that his therapy had not been scientifically controverted anywhere in the world since 2013, wondered why some people were still sceptical about the landmark discovery which he said had already been published in some leading international journals.